The Cannigma

MARCH 18, 2021

Taken together, the lack of guidance and lack of information about what treatments patients are taking, may underlie “inconsistencies in both use and reported effectiveness,” the researchers stated. Here are the most interesting statistics from the survey. “If

Patients 138

Patients Clinical Trials Treatment Cannabis 138

The Cannigma

MARCH 7, 2022

What can the current clinical trials tell us? A common theme with cannabis is that more research is needed, so thankfully there are clinical trials in the works looking at the therapeutic utility of CBN. Those enrolled in the study will receive 28 days of treatment and then be assessed by pain-rating scales.

THC 139

THC Sleep Clinical Trials Cannabinoids 139

Cannabis Law Report

AUGUST 10, 2021

This acquisition is focused on becoming the first and only company solving the puzzle of chronic pain with MDMA-based medicines utilizing clinical trials for the purposes of novel drug development. The global chronic pain treatment market is predicted to progress at a CAGR of 6.5% from 2020 to 2030 and generate revenue of $151.7

Chronic Pain 105

Chronic Pain Clinical Trials Research and Development Events 105

MGC Pharma

FEBRUARY 20, 2018

The Top Medical Cannabis Research of 2017 A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals MGC Pharma is still riding off the success of 2017 as we progress into 2018, with many exciting developments on the horizon.

Research and Development 100

Research and Development Clinical Trials Patients Chronic Pain 100

Veriheal

OCTOBER 20, 2023

Michigan’s decision to end pre-employment drug testing is motivated by the fact that the state already legalized recreational cannabis back in 2018. The vote represents the employees’ desire for fair treatment and recognition for their efforts within the industry.

Policy 110

Policy Clinical Trials Research and Development Dispensary 110

CannaTech

SEPTEMBER 23, 2019

In the UK, cannabis-based medicinal products (CBMP) were legalized in November 2018. This bottleneck has left patients and parents to pursue unregulated avenues to access treatment. Furthermore, pharmaceutical companies often fund and initiate randomised clinical trials to validate their drugs.

Patients 79

Patients Policy Clinical Trials Research and Development 79

MedicalJane

OCTOBER 3, 2019

The United States Department of Defense and GW Pharmaceuticals are collaborating on a new clinical trial at the Montefiore Medical Center in New York. Dr. Eric Hollander, the Director of the Autism and Obsessive Compulsive Spectrum Program and Anxiety and Depression Program at Montefiore Hospital, is leading the clinical trial.

Clinical Trials 74

Clinical Trials Epilepsy Pharmaceutical Treatment 74

Peninsula Alternative Health

MAY 15, 2019

Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. Of 272 combined patients, 86% experienced some clinical benefit, and 10% experienced a complete clinical response. tetrahydrocannabinol (THC).

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

Cannabis Info

OCTOBER 11, 2019

Cannabis & Dementia: New Study Explores Pot’s Potential for Treatment. In the decades since the medical marijuana movement began in earnest in the 1970s, cannabis has been anecdotally touted as an effective treatment for a variety of illnesses, including those impacting brain function, such as seizures, anxiety and depression.

Treatment 45

Treatment Clinical Trials Cannabinoids Cannabis 45

Veriheal

JULY 12, 2021

According to data on Healthy Place , treatment for PTSD is typically accommodated for the general public, of who the vast majority have not experienced military combat. At this time, there is little in the way for combat-related PTSD treatment specifically. But veterans utilize general PTSD treatment and still experience recovery.

Treatment 105

Treatment Sleep Clinical Trials Data 105

Cannabis Law Report

SEPTEMBER 1, 2021

The company recently became the industry’s first firm to list on the NYSE American exchange and their psilocybin clinical trial for depression is making excellent progress. His background is a mix of cognitive psychology, clinical psychology and computer science. After Approval, It’s Off to Treatment Clinics.

Research and Development 102

Research and Development Therapy Clinical Trials Pharmaceutical 102

Puff Puff Post

OCTOBER 3, 2019

The possibility of treating the symptoms associated with autism originated when the FDA approved Epidoliolex in 2018. Not only did the success influence the European Commission to approve Epidoliolex , but it also sparked motivation to develop a similar treatment for other disorders.

Research and Development 94

Research and Development Epilepsy Clinical Trials Treatment 94

Kind Meds (Cannabis Education Blog)

JANUARY 9, 2019

The first-ever cannabis-based drug with FDA approval is Epidiolex*, a new prescription drug designed to treat severe seizure disorders that do not respond to other treatments. After securing FDA approval in June of 2018, Epidiolex’s manufacturer GW Pharma announced the drug should enter the consumer market by the end of 2018.

Research and Development 97

Research and Development Treatment Pharmaceutical Conditions 97

The Cannigma

MARCH 25, 2021

When the law changed in the UK in 2018, I was humbled by the efforts of those who suffer on a daily basis to achieve legal access to medicinal cannabis. I also advocated alongside my partner for many years as part of the patient group United Patients Alliance. I remain in awe of these patients to this day.

Patients 145

Patients Clinical Trials Medicine Events 145

Cannabis Law Report

JULY 6, 2021

Professor Allan Young, Head of Academic Psychiatry at King’s IoPPN, said, “We have been in partnership with SLaM at the Maudsley Biomedical Research Centre since 2007, and with COMPASS on COMP360 psilocybin therapy research since 2018. George Goldsmith, CEO and Co?founder,

Research and Development 76

Research and Development Clinical Trials Therapy Patients 76

CannaMD

NOVEMBER 6, 2019

In the fall of 2018, scientists at the San Francisco Veterans Affairs Medical Center released findings from a survey on the subject of marijuana versus opioids. billion opioid prescriptions written between 2011 and 2018. Medical cannabis is an effective and safe alternative for pain treatment. Using Cannabis to Quit Opioids.

Marijuana 107

Marijuana Patients Clinical Trials Data 107

Canna Law Blog

MARCH 4, 2020

In recent years, the United States has seen a proliferation of ketamine clinics. From 2015 to 2018, the number of clinics increased from 60 to 300; that number is undoubtedly higher today. People are increasingly using ketamine for ailments that resist treatment through traditional pharmaceutical drugs.

Therapy 101

Therapy Legalization Chronic Pain DEA 101

MMJ Recs

NOVEMBER 20, 2023

Epilepsy Management: CBD, in particular, has emerged as an effective treatment for epilepsy, especially in individuals with rare and severe forms of the condition. Neurological Disorders: Several cannabinoids show promise in the treatment of neurological disorders, including multiple sclerosis (MS) and Parkinson’s disease.

Cannabinoids 98

Cannabinoids Epilepsy Treatment Marijuana 98

Cannabis Law Report

JANUARY 3, 2022

(Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication and substance abuse, announces that the first patient has been dosed in a Phase 2 proof-of-concept clinical study investigating ANEB-001 as a potential treatment for acute cannabinoid intoxication.

Pharmaceutical 52

Pharmaceutical Cannabinoids Treatment Clinical Trials 52

CannaMD

AUGUST 26, 2020

Current Cocaine Treatments. As researchers point out: There is no gold standard pharmacological treatment for dependence on cocaine. Although several drugs have been investigated, there is no strong or consistent evidence indicating any of these drugs for the treatment of cocaine use disorder. mice/rats).

Therapy 98

Therapy CBD Research and Development Treatment 98

Project CBD

FEBRUARY 28, 2023

5 In June 2018, the FDA approved Epidiolex® (GW Pharmaceuticals; Cambridge, UK), the first FDA-approved pharmaceutical drug to contain a “purified drug substance [CBD] derived from marijuana,” for the treatment of seizures associated with two rare epilepsy disorders. Silver Spring, MD: US Food and Drug Administration; June 25, 2018.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

DECEMBER 14, 2019

million in the Melbourne cannabis firm in 2018. Export markets have also continued to open up, according to Bell and Smith, since the shipment of the drug out of the country was legalized in 2018. A 2018 report from Prohibition Partners has forecasted that medical cannabis in Australia could be worth US$2.13

Pharmaceutical 98

Pharmaceutical Patients Clinical Trials Hemp 98

Healer

MARCH 26, 2021

Gresh has joined a growing number of patients who swear by medical cannabis not only as a treatment option for chronic pain, but also as a substitute for prescription opioids used in pain management. They’re an effective treatment for pain, but they’re not great for chronic pain, and many people are reluctant to start on opioids,” he said.

Chronic Pain 86

Chronic Pain Clinical Trials Treatment Patients 86

Medical Marijuana Program Connection

JANUARY 16, 2024

Rowena Naylor/Stocksy United Cannabidiol (CBD) has been approved for use in the treatment of two early-onset, intractable forms of epilepsy, Dravet syndrome and Lennox-Gastaut syndrome, since 2018. This decision followed clinical trials showing. Read More

Clinical Trials 40

Clinical Trials CBD Epilepsy Treatment 40

CannaMD

NOVEMBER 8, 2019

VA providers can and do discuss marijuana use with veterans as part of comprehensive care planning, and adjust treatment plans as necessary. VA health care providers will record marijuana use in the veteran’s VA medical record in order to have the information available in treatment planning. VidaCann : 15% discount.

Marijuana 85

Marijuana Treatment Research and Development Patients 85

Cannabis Law Report

MAY 31, 2022

The only psychedelic drug that is approved (outside of clinical trials) for psychiatric use—as opposed to anesthesia—through the traditional medical system is Ketamine. Food and Drug Administration (FDA) approved esketamine (a component of Ketamine and sold under the brand name Spravato) for treatment-resistant depression.

Clinical Trials 52

Clinical Trials Legalization Therapy Decriminalization 52

The Cannigma

MAY 6, 2021

Other than serving as a lighter version of delta-9-THC, delta-8 has also been researched as a potential treatment for a number of medical conditions and symptoms such as vomiting and nausea, glaucoma, pain, and inflammation. The only clinical trial on delta-8-THC involving humans was done on children in Israel in 1995.

THC 145

THC Cannabinoids Concentrates Hemp 145

The Cannigma

JUNE 23, 2022

Another study published in 2018 investigated the effects of CBD/CBDA and CBG/CBGA on aldose reductase, an enzyme responsible for glucose formation. And while some are hopeful for the potential of CBGA, most experts are not yet convinced of cannabinoids as prevention or treatment of COVID infections. Where can you buy CBGA?

Cannabinoids 113

Cannabinoids Research and Development Clinical Trials Extraction 113

CannaMD

AUGUST 8, 2020

More recently, the 2018 Farm Bill expanded hemp legislation. 27, 2018, the DEA announced a rule change that placed “FDA-approved drugs that contain CBD derived from cannabis and no more than 0.1 On June 25, 2018, Epidiolex became the first FDA approved cannabis-derived medication to hit U.S. In 1970, the U.S.

CBD 105

CBD DEA Research and Development Hemp 105

Cannabis Law Report

OCTOBER 20, 2021

Mr Blunt said it had “exciting potential” for the treatment of mental health conditions such as depression, trauma and addiction. It would then potentially be in the same category as medical cannabis, which was legalised in 2018.

Supply Chain 52

Supply Chain Clinical Trials Therapy Treatment 52

Cannabis Law Report

JULY 1, 2021

Clinical trials repeatedly demonstrate their promise for treating mood, anxiety, and substance use disorders. In 2017, the FDA designated MDMA a breakthrough therapy for post-traumatic stress disorder, and in 2018 the agency identified psilocybin as a breakthrough for treatment-resistant depression.

Law 59

Law Policy Research and Development Clinical Trials 59

Medical Cannabis Seedbank

FEBRUARY 26, 2018

Unfortunately, many of those victims are either unaware or simply have not been given the option of alternative treatments to the more orthodox chemotherapy. The alternative treatment that we will focus on in this post is the use of medical cannabis and its healing qualities. Countries such as the U.S.A Encourage appetite.

Treatment 63

Treatment Patients Clinical Trials THC 63

Veriheal

AUGUST 31, 2020

Essay: “Integrating Research and Medicine: Cannabis Related Treatment for Neurodegenerative Diseases”. Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Nishtha Tripathi. Program between St.

Research and Development 119

Research and Development Education Agriculture Patients 119

The Cannigma

JUNE 15, 2021

The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. CBG, however, also has some medicinal potential that CBD doesn’t, for instance as a treatment for hypertension and insulin resistance. Shutterstock).

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

MAY 12, 2022

Lophora has previously secured grant funding from the BioInovation Institute (Novo Nordisk Foundation) and continues to characterise its lead candidates, aiming to initiate clinical trials in 2023. Lophora is a drug-development company founded in 2018 in Copenhagen, Denmark. Lophora – www.lophora.com.

Medicine 52

Medicine Research and Development Clinical Trials Treatment 52

Healer

DECEMBER 17, 2021

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions. Based on my clinical experience, it is rare for people to experience CBD-drug interactions at doses below 100mg daily. . Epilepsy & behavior case reports 9 (2018): 10.

CBD 98

CBD THC Conditions Medicine 98

Cannabis Law Report

MARCH 2, 2020

In 2018, the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy designation (BTD) to Compass Pathways ‘ psilocybin therapy for treatment-resistant depression. First up, cannabis has now been scientifically validated as a treatment for two severe forms of childhood epilepsy (more on this in a moment).

Medicine 59

Medicine Therapy DEA Pharmaceutical 59